Zimura in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Status:
Completed
Trial end date:
2020-04-23
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the safety and efficacy of intravitreous
administration of Zimura when administered in subjects with geographic atrophy (GA) secondary
to dry age-related macular degeneration (AMD).